Learn
Insights
Tax tips, options trading ideas, and market takes — updated regularly.
All
Market Commentary
Options Strategies
Retirement & Income
Stock Research
Tax Planning
Trading Psychology
filtered by tag — clear
Market Commentary
Vertex's $10 Billion Crinetics Deal: Why the Target Popped 99% and the Buyer Fell
Vertex Pharmaceuticals is paying $10 billion, a 102% premium, for Crinetics Pharmaceuticals. Crinetics stock nearly doubled overnight. Vertex stock dropped. Neither reaction means what it looks like it means — here's the mechanic behind both.